معرفی
Dr. Osborne Wong is a research professional affiliated with the Department of Chemistry at the University of Kansas. He has held positions such as Section Leader of Analytical Pharmaceutical Chemistry at Oread Laboratories Inc., Director of Analytical Sciences at Cygnus Inc., and Assistant Director of the Center for BioAnalytical Research at KU. His career has focused on pharmaceutical product development, including contributions to FDA-regulated drug formulations like Salmeterol (Serevent®), Amifostine (Ethyol®), and Integrilin®.
- B.S. in Chemistry, Central Missouri State University, 1977
- Ph.D. in Chemistry, University of Kansas, 1983
- MBA, University of Kansas, 2006
Dr. Wong's expertise lies in analytical chemistry applications for pharmaceutical stability testing, drug formulation design, and FDA compliance. He has managed multi-year programs supporting New Drug Applications and contributed to commercial injectable liquid formulation development. While no specific scientific awards are mentioned in the provided text, his career spans both academic research and industry leadership roles.
As an affiliated researcher, Dr. Wong has driven translational research initiatives through positions at KU's Center for BioAnalytical Research and related pharmaceutical enterprises. His work bridges academic chemistry research with real-world drug development and regulatory processes.
